COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Molecular Interactions
Last updated: 2024 Feb 18
Total hit(s): 5230
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38361363
Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38717195
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.
Virulence
2024 Dec
4.81
1
4
38304547
Binding affinity between coronavirus spike protein and human ACE2 receptor.
Comput Struct Biotechnol J
2024 Dec
5.11
1
5
38704887
Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.
Biochem Biophys Res Commun
2024 Jul 5
2.73
1
6
38640732
Computational investigation of the inhibitory interaction of IRF3 and SARS-CoV-2 accessory protein ORF3b.
Biochem Biophys Res Commun
2024 Jun 18
2.73
1
7
38652363
Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
Daru
2024 Jun
2.72
1
8
38724525
Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July-December, 2022.
Sci Rep
2024 May 9
4.12
1
9
38718213
Characterization of nsp1 Binding to the Viral RNA Leader Sequence of Severe Acute Respiratory Syndrome Coronavirus.
Biochemistry
2024 May 8
2.952
1
10
38686454
Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design.
Phys Chem Chem Phys
2024 May 8
6.3
1
11
38717584
Ultra-Sensitive Detection of the SARS-CoV-2 Nucleocapsid Protein via a Clustered Regularly Interspaced Short Palindromic Repeat/Cas12a-Mediated Immunoassay.
ACS Sens
2024 May 8
6.88
1
12
38713096
Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
Ann Clin Transl Neurol
2024 May 7
7
1
13
38715364
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immune responses in mice.
Mol Ther
2024 May 6
17
2
14
38714446
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
Vaccine
2024 May 6
3.31
1
15
38710880
Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.
Nat Nanotechnol
2024 May 6
56.7
1
16
38704475
Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer.
Sci Rep
2024 May 4
4.12
1
17
38703336
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Infect Dis Ther
2024 May 4
3.95
1
18
38703305
Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19.
Mol Biotechnol
2024 May 4
4.8
1
19
38758996
Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East Respiratory Syndrome Corona Virus.
Hum Antibodies
2024 May 2
1.5
1
20
38706870
Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2.
iScience
2024 May 17
4.447
1
21
38638575
Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient.
iScience
2024 May 17
4.447
1
22
38759218
Molecular docking based comparative study of antiviral compounds on SARS-CoV-2 spike protein.
Nat Prod Res
2024 May 17
3.9
1
23
38753442
Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.
Eur J Microbiol Immunol (Bp)
2024 May 16
1
24
38694063
Role of ribosomal pathways and comorbidity in COVID-19: Insight from SARS-CoV-2 proteins and host proteins interaction network analysis.
Heliyon
2024 May 15
1.65
1
25
37698016
Interleukin 13-Induced Inflammation Increases DPP4 Abundance but Does Not Enhance Middle East Respiratory Syndrome Coronavirus Replication in Airway Epithelia.
J Infect Dis
2024 May 15
4.73
1